| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1535-7163.MCT-05-0161 |
| P8608 | Fatcat ID | release_wlxgbyzdnbhi5ppr2xq6sypd3m |
| P698 | PubMed publication ID | 16170035 |
| P2093 | author name string | Werner Tjarks | |
| Rolf F Barth | |||
| Joseph M Backer | |||
| Marina V Backer | |||
| Vimal Patel | |||
| Achintya K Bandyopadhyaya | |||
| Timur I Gaynutdinov | |||
| Kevin Claffey | |||
| B T S Thirumamagal | |||
| P433 | issue | 9 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1423-1429 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature | |
| P478 | volume | 4 |
| Q26773577 | Angiogenic factors, bladder neuroplasticity and interstitial cystitis-new pathobiological insights |
| Q93074166 | BNCT induced immunomodulatory effects contribute to mammary tumor inhibition |
| Q34194191 | Bioengineering strategies for designing targeted cancer therapies |
| Q37575433 | Biohybrid polymer capsules |
| Q37095894 | Boron Neutron Capture Therapy for Malignant Brain Tumors |
| Q89141802 | Boron delivery agents for neutron capture therapy of cancer |
| Q40026377 | Chapter 7. Molecular imaging of tumor vasculature |
| Q21203116 | Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer |
| Q57556323 | Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine |
| Q26746182 | Dendritic Polymers for Theranostics |
| Q39041183 | Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles |
| Q34952473 | Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform |
| Q33712697 | Development of Responsive Lanthanide-Based Magnetic Resonance Imaging and Luminescent Probes for Biological Applications |
| Q37804385 | Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery |
| Q37771030 | Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). |
| Q34666766 | Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions |
| Q37487137 | Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculature |
| Q35999557 | Imaging key biomarkers of tumor angiogenesis |
| Q36469164 | Imaging of tumor angiogenesis: functional or targeted? |
| Q40280042 | In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF. |
| Q35635676 | Inhibition of anthrax protective antigen outside and inside the cell |
| Q37633122 | Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature |
| Q48408217 | Liposomal boron delivery for neutron capture therapy |
| Q38796320 | Modifying the tumor microenvironment using nanoparticle therapeutics |
| Q34183087 | Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas |
| Q40160655 | Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes |
| Q59113879 | Multifunctional Silica Nanoparticles Modified via Silylated-Decaborate Precursors |
| Q37087186 | N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers |
| Q38523681 | Nanocarriers for cancer-targeted drug delivery. |
| Q37857064 | Nanomaterials: applications in cancer imaging and therapy. |
| Q34259986 | Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications |
| Q38682486 | Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment |
| Q37470319 | Nanoparticulate systems for growth factor delivery |
| Q38165639 | Nanopreparations for organelle-specific delivery in cancer |
| Q37939942 | Nanostructure-based drug delivery systems for brain targeting. |
| Q21195857 | Nanotechnology-mediated targeting of tumor angiogenesis |
| Q92505113 | Near-infrared imaging of diseases: A nanocarrier approach |
| Q39652806 | Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment. |
| Q36752048 | Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies |
| Q30472543 | Optical imaging of rheumatoid arthritis |
| Q91827983 | Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy |
| Q38114360 | Polymeric materials for theranostic applications |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q59689539 | Präklinische Bildgebung im Tiermodell bei Strahlentherapie |
| Q39941113 | Quantitative PET imaging of VEGF receptor expression |
| Q37237705 | Radionuclide carriers for targeting of cancer |
| Q51743823 | Site-specific protection and dual labeling of human epidermal growth factor (hEGF) for targeting, imaging, and cargo delivery. |
| Q42413750 | Specific Targeting of Tumor Endothelial Cells by a Shiga-like Toxin-Vascular Endothelial Growth Factor Fusion Protein as a Novel Treatment Strategy for Pancreatic Cancer |
| Q24296700 | Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling |
| Q37038825 | Targeted nanomaterials for radiotherapy |
| Q30455820 | Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer. |
| Q36790262 | The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain |
| Q38847912 | The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases |
| Q24621214 | Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer |
| Q37171165 | Tumour and dendrimers: a review on drug delivery aspects. |
| Q35545371 | Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2. |
| Q37694413 | Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals |
| Q36807118 | VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation. |
| Q30455612 | Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy |
| Q30725740 | Visualization, imaging and new preclinical diagnostics in radiation oncology |
| Q30425448 | scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis |
Search more.